Stimulant Medications: A Trade‐off? The Lived Experience of Adolescents With ADHD
Open accessAbstract
PURPOSE. The purpose of this study was to gain information and insight about prescription stimulant medication use among children and adolescents with attention deficit–hyperactivity disorder (ADHD) across developmental stages. DESIGN AND METHODS. Investigators conducted semistructured qualitative interviews with 15 college students with ADHD. Follow‐up interviews confirmed and validated information obtained during initial interviews. RESULTS. Qualitative data analysis resulted in three global categories related to the use of prescription stimulant medication from childhood to late adolescence: (a) the early years, (b) “the trade‐off,” and (c) stimulant medications in college. PRACTICE IMPLICATIONS. Increased education about prescription stimulant medications and closer management is needed to reduce side effects and minimize the risks of misuse.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Negative emotion-related side effects of stimulant medications such as worsened EL has been cited in several studies as the main cause of treatment cessation.
“Negative emotion-related side effects of stimulant medications such as worsened EL has been cited in several studies as the main cause of treatment cessation (Brinkman et al., 2012; Findling et al., 2011; Meaux et al., 2006)”
From A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials (2024) · cites this paper as Meaux et al., 2006
The paper’s discussion of side effects reports that participants experienced emotional lability and anger while taking stimulants. Its discussion of stopping treatment also describes concerns about identity and a desire for independence; it does not establish worsened emotional lability as the main cause of cessation. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Continuity of Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder
Marcus, S. C., Wan, G. J., Kemner, J. E., & Olfson, M. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.6.572 · Cited by 163 · see citing works
Flagged first, then by citations
Research works printed but not linked: 14
- American Academy of Pediatrics. (2001). Clinical practice guide- line: Treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics , 108 (4), 1033 -1044.
- Barkley, R. (1998). Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment. New York: The Guilford Press.
- Barkley, R., Murphy, K., DuPaul, G., & Bush, T. (2002). Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. Journal of the International Neuropsycho- logical Society , 8 , 655 -672.
- Barkley, R., Murphy, K., & Kwasnik, D. (1996). Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics , 98 (6), 1089- 1095.
- Centers for Disease Control and Prevention. (2005). Mental health in the United States: Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder -United States 2005. Morbidity and Mortality Weekly Report , 54 (34), 842 -847.
- Hall, K., Irwin, M., Bowman, K., Frankenberger, W., & Jewett, D. (2005). Illicit use of prescribed stimulant medication among college students. Journal of American College Health , 53 (4), 167-174.
- Kollins, S.H., Barkley, R.A., & DuPaul, G.J. (2001). Use and manage- ment of medications for children diagnosed with attention deficit hyperactivity disorder (ADHD). Focus on Exceptional Children , 33 (5), 1-24.
- Krueger, M., & Kendall, J. (2001). Descriptions of self: An exploratory study of adolescents with ADHD. Journal of Child and Adolescent Psychiatric Nursing , 14 (2), 61-72.
- Olfson, M., Marcus, S.C., Weissman, M.M., & Jensen, P.S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry , 41 (5), 514 -521.
- National Institutes of Health Consensus Development Conference Statement: Diagnosis and treatment of attention-deficit/hyperac- tivity (ADHD). (February, 2000). Journal of the American Academy of Child & Adolescent Psychiatry , 39 (2), 182 -193.
- Rowland, A.S., Lesesne, C.A., & Abramowitz, A.J. (2002). The epidemiology of attention-deficit/hyperactivity disorder (ADHD). Mental Retardation Developmental Disability Research Review , 8 (1), 70.
- Schachter, H.M., Pham, B., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal , 165 (11), 1475 -1488.
- Wender, E. (1995). Attention-deficit hyperactivity disorders in ado- lescence. Journal of Developmental and Behavioral Pediatrics , 16 (3), 192-195.
- Wolraich, M., Wibbelsman, C., Brown, T., Evans, S., Gotlieb, E., Knight, J., et al. (2005). Attention-deficit/hyperactivity disorder among adolescents: A review of the diagnosis, treatment, and clinical implications. Pediatrics , 115 (6), 1734 -1746.
Cited by
Sorted by citations
DuPaul, G. J., Weyandt, L. L., Rossi, J. S., Vilardo, B. A., O’Dell, S. M., Carson, K. M., Verdi, G., & Swentosky, A. (2012) · Journal of Attention Disorders · doi:10.1177/1087054711427299 · Cited by 86 · see citing works
Improving Medication Adherence in Chronic Pediatric Health Conditions: A Focus on ADHD in Youth
Chacko, A., H. Newcorn, J., Feirsen, N., & Z. Uderman, J. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791959908 · Cited by 66 · see citing works
ADHD among a cohort of ethnic minority women
Waite, R., & Tran, M. (2010) · Women & Health · doi:10.1080/03630241003601095 · Cited by 15 · see citing works
Arnold, V. K., López, F. A., Childress, A. C., Po, M. D., Uchida, C. L., Cuthbertson, L., Sallee, F. R., & Incledon, B. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241243155 · Cited by 1 · see citing works
“…effects of stimulant medications such as worsened EL has been cited in several studies as the main cause of treatment cessation (Brinkman et al., 2012; Findling et al., 2011; Meaux et al., 2006), therefore understanding the impact of a medication on EL prior to starting a new regimen is important.”
Background
- Authors
- Meaux, J. B., Hester, C., Smith, B., & Shoptaw, A.
- Affiliations
- University of Central Arkansas (US)
- University of Arkansas for Medical Sciences (US)
- Venue
- Journal for Specialists in Pediatric Nursing
- Publisher
- Wiley
- Published
- 2006-09-21
- Volume
- 11
- Issue
- 4
- Pages
- 214-226
- ISSN
- 1539-0136 (ISSN-L)
- 1744-6155
- OpenAlex
- W1967030813
- Cited by
- 81
- References
- 1
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 9 · 2023: 5 · 2022: 2 · 2021: 3 · 2020: 5 · 2018: 3 · 2017: 6 · 2016: 3 · 2015: 4 · 2014: 4 · 2013: 3 · 2012: 7
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal for Specialists in Pediatric Nursing (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- attention deficit hyperactivity disorder, adolescents, lived experience, adverse drug reactions, medication misuse, university students, developmental stages, medication education, medication management
- MeSH terms
- Adaptation, Psychological, Adolescent, Adolescent Behavior, Psychology, Adolescent, Adult, Central Nervous System Stimulants, Arkansas, Attention Deficit Disorder with Hyperactivity, Attitude to Health, Female, Follow-Up Studies, Health Services Needs and Demand, Humans, Male, Motivation, Patient Education as Topic, Peer Group, Surveys and Questionnaires, Self Care, Shame, Students, Universities, Nursing Methodology Research, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
